YAM DOUBLE CARE FLUID SPF17 PA Plus Plus
Dosage form: cream
Ingredients: OCTINOXATE 5.6mL in 140mL, AVOBENZONE 2.1mL in 140mL, ENSULIZOLE 1.4mL in 140mL
Labeler: SKINFOOD CO., LTD.
NDC Code: 76214-015
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Active ingredients: OCTINOXATE 4.0%, AVOBENZONE 1.5%, ENSULIZOLE 1.0%
Inactive ingredients:
WATER, DIISOPROPYL SEBACATE, ALCOHOL DENAT., POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE, PHENETHYL BENZOATE, ARBUTIN, 4-METHYLBENZYLIDENE CAMPHOR, DIMETHICONE, 1,2-HEXANEDIOL, SODIUM HYDROXIDE, GLYCERYL STEARATE, PEG-100 STEARATE, CARBOMER, DISODIUM EDTA, DIOSCOREA JAPONICA ROOT EXTRACT, XANTHAN GUM,
TOCOPHERYL ACETATE, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, PHENOXYETHANOL, METHYLPARABEN, BUTYLPARABEN, FRAGRANCE
Purpose: Protects skin from UV rays.
Warnings:
For external use only. Avoid contact with eyes.
Discontinue use if signs of irritation appear.
Keep out of reach of children:
Keep out of reach of children.
Indication and usage: Apply on skin liberally.
Dosage and administration: Dispense an ample amount and apply a thin layer onto the skin.
| YAM DOUBLE CARE FLUID
SPF17 PA PLUS PLUS
octinoxate cream |
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
| Labeler - SKINFOOD CO., LTD. (690324173) |
| Registrant - SKINFOOD CO., LTD. (690324173) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| SKINFOOD CO., LTD. | 690324173 | manufacture | |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
